Article ID Journal Published Year Pages File Type
10966566 Vaccine 2013 10 Pages PDF
Abstract
► Two BCEs and seven TCEs are synthesized as epitope-based peptide-vaccine of PRRSV. ► We use the N terminal 22-355 aa of porcine gp96 (Gp96N) as the adjuvant. ► TCE-peptides can induce strong cellular immune responses and Gp96N can enhance it. ► Gp96N could improve innate and adaptive immunity with Th1 biased immune response. ► This vaccine can partly alleviate symptoms caused by HP-PRRSV challenge.
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , , , , , , , ,